Breaking News
About Johnson & Johnson
Profound Change Requires Boldness.
Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years.
The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the health of their skin. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world.
Social Media Community Guidelines:
http://www.jnj.com/social-media-community-guidelines
Related Story
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 14 2023
Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
December 1 2022
Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin […]
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 21 2022
Johnson & Johnson (NYSE: JNJ) (the Company) today opened its San Francisco Bay Campus, a […]
PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
August 18 2022
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of […]
Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
May 12 2022
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]
Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus
May 10 2022
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration […]
Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
February 16 2022
Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older
November 25 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved […]
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
October 21 2021
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) […]
DePuy Synthes Introduces the INHANCE ™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
August 19 2021
Today, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company […]
Ethicon's Echelon Circular Powered Stapler Associated with Major Reduction in Serious Complications Following Colorectal Surgery
August 11 2021
Ethicon, part of the Johnson & Johnson Medical Devices Companies, today announced the results of […]
MedTech Innovator Selects 20 Premier Startups for Annual Asia Pacific Accelerator
July 14 2021
MedTech Innovator, the largest accelerator of medical device companies in the world, in partnership with Asia […]
Janssen single dose Covid-19 vaccine authorised by UK medicines regulator
June 1 2021
Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
May 14 2021
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]